CAROLINA: Cardiovascular Outcome Study of Linagliptin versus Glimepiride in Patients with Type 2 Diabetes
The aim of the study is to investigate the lengthy-time period influence on cardiovascular morbidity and mortality, relevant efficacy parameters (e.g., glycaemic parameters) and security (e.g., weight and hypoglycaemia) of remedy with linagliptin in patients with kind-2 diabetes at multiplied cardiovascular chance receiving general care, and evaluate outcome towards glimepiride.
